Nemaura Medical NMRD
$ 0.11
-17.8%
Quarterly report 2023-Q4
added 02-12-2024
Nemaura Medical Balance Sheet 2011-2024 | NMRD
Annual Balance Sheet Nemaura Medical
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -23.5 K | -3.74 M | -822 K | -911 K | -9.4 M | -355 K | -1.87 M | - | - | - | ||
Long Term Debt |
3.09 M | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
16.9 M | 19.2 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.15 M | 1.24 M | 1.33 M | 1.18 M | 1.4 M | 1.71 M | 1.67 M | - | - | - |
Total Current Liabilities |
22.3 M | 20.6 M | 6.42 M | 1.39 M | 1.3 M | 811 K | 852 K | 658 K | 122 K | - | - | - | - |
Total Liabilities |
26.4 M | 21.6 M | 26.9 M | 2.53 M | 2.54 M | 2.14 M | 2.04 M | 2.05 M | 1.83 M | 1.68 M | - | - | - |
Deferred Revenue |
124 K | 259 K | 103 K | 93 K | 65.2 K | - | - | - | - | - | - | - | - |
Retained Earnings |
-51.9 M | -37.7 M | -23.8 M | -17.6 M | -13.4 M | -8.97 M | -7.15 M | -5.6 M | -4.06 M | -2.74 M | - | - | - |
Total Assets |
14.6 M | 22.1 M | 35.2 M | 1.22 M | 4.76 M | 6.26 M | 7.4 M | 9.73 M | 913 K | 2.05 M | - | - | - |
Cash and Cash Equivalents |
10.1 M | 17.7 M | 31.9 M | 106 K | 3.74 M | 822 K | 911 K | 9.4 M | 355 K | 1.87 M | - | - | - |
Book Value |
-11.8 M | 466 K | 8.36 M | -1.31 M | 2.23 M | 4.11 M | 5.37 M | 7.68 M | -917 K | 374 K | - | - | - |
Total Shareholders Equity |
-11.8 M | 466 K | 8.36 M | -1.31 M | 2.23 M | 4.11 M | 5.37 M | 7.68 M | -917 K | 374 K | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Nemaura Medical
2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 3.36 M | 119 K | 3.09 M | - | - | - | - | - | - | - | 24.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 5.72 M | 1.05 M | 9.91 M | 10 M | 15.3 M | 20.5 M | 2.96 M | 3.98 M | 3.38 M | 1.15 M | - | - | - | - | - | - | - | 1.33 M | 1.25 M | 1.27 M | 1.2 M | 1.18 M | 1.18 M | 1.26 M | 1.27 M | 1.4 M | 1.52 M | 1.56 M | 1.52 M | 1.71 M | 1.57 M | 1.66 M | 1.69 M | 1.67 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
23 M | 24.8 M | 22.8 M | 26.4 M | 22.8 M | 24.9 M | 23.7 M | 21.6 M | 26.1 M | 27.2 M | 27.7 M | 26.9 M | 7.31 M | 6.87 M | 6.96 M | 2.53 M | 2.4 M | 2.51 M | 2.67 M | 2.54 M | 2.59 M | 2.33 M | 2.46 M | 2.14 M | 2.3 M | 2.07 M | 2.24 M | 2.04 M | 2.16 M | 2.12 M | 2.14 M | 2.05 M | 2.11 M | 2.11 M | 1.88 M | 1.83 M | 1.62 M | 1.81 M | 1.8 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
1.18 M | 1.13 M | 127 K | 124 K | 69.7 K | 71 K | 178 K | 259 K | 463 K | 625 K | 629 K | 103 K | 102 K | 96.9 K | 94.3 K | 93 K | 66 K | 61.6 K | 36 K | 65.2 K | 98.6 K | 97.8 K | 66 K | 70.2 K | - | - | - | - | - | - | - | - | - | - | 38.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-57.8 M | -55.7 M | -54.5 M | -51.9 M | -47.2 M | -45.8 M | -41.7 M | -37.7 M | -34.1 M | -30.7 M | -27.2 M | -23.8 M | -21.7 M | -20.3 M | -18.7 M | -17.6 M | -16.2 M | -15.8 M | -14.7 M | -13.4 M | -11.8 M | -10.9 M | -9.74 M | -8.97 M | -8.42 M | -7.95 M | -7.56 M | -7.15 M | -6.79 M | -6.42 M | -6.1 M | -5.6 M | -5.18 M | -4.85 M | -4.46 M | -4.06 M | -3.53 M | -3.37 M | -3.01 M | -2.74 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
5.17 M | 8.92 M | 8.45 M | 14.6 M | 13 M | 15.9 M | 19.7 M | 22.1 M | 27.1 M | 31.6 M | 35.7 M | 35.2 M | 17.6 M | 18.1 M | 8.92 M | 1.22 M | 2.16 M | 2.7 M | 3.98 M | 4.76 M | 5.75 M | 4.38 M | 5.57 M | 6.26 M | 6.8 M | 7 M | 7.41 M | 7.4 M | 7.86 M | 8.59 M | 8.8 M | 9.73 M | 10.1 M | 380 K | 552 K | 913 K | 1.24 M | 1.57 M | 1.9 M | 2.05 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
137 K | 1.38 M | 4.01 M | 10.1 M | 7.34 M | 10.1 M | 14.8 M | 17.7 M | 23 M | 26.8 M | 31.3 M | 31.9 M | 15 M | 15 M | 16.9 M | 5.95 M | 1.07 M | 1.07 M | 1.77 M | 3.07 M | 5.04 M | 526 K | 320 K | 822 K | 1.66 M | 598 K | 1.28 M | 911 K | 7.59 M | 8.32 M | 8.49 M | 9.4 M | 9.85 M | 99.8 K | 126 K | 355 K | 614 K | 907 K | 1.11 M | 1.87 M | 6.83 K | 28.3 K | 17.4 K | 200 K | - | - | - | - | - | - | - | - |
Book Value |
-17.8 M | -15.9 M | -14.4 M | -11.8 M | -9.86 M | -9.01 M | -3.96 M | 466 K | 1.02 M | 4.37 M | 7.97 M | 8.36 M | 10.3 M | 11.2 M | 1.96 M | -1.31 M | -235 K | 196 K | 1.31 M | 2.23 M | 3.16 M | 2.05 M | 3.11 M | 4.11 M | 4.5 M | 4.93 M | 5.16 M | 5.37 M | 5.7 M | 6.47 M | 6.65 M | 7.68 M | 7.99 M | -1.73 M | -1.33 M | -917 K | -381 K | -246 K | 101 K | 374 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-17.8 M | -15.9 M | -14.4 M | -11.8 M | -9.86 M | -8.7 M | -3.87 M | 466 K | 1.02 M | 4.37 M | 7.97 M | 8.36 M | 10.3 M | 10.3 M | 11.2 M | 1.96 M | -235 K | -235 K | 196 K | 2.23 M | 3.16 M | 2.05 M | 3.11 M | 4.11 M | 4.5 M | 4.93 M | 5.16 M | 5.37 M | 5.7 M | 6.47 M | 6.65 M | 7.68 M | 7.99 M | -1.73 M | -1.33 M | -917 K | -381 K | -246 K | 101 K | 374 K | - | - | - | 258 K | - | - | - | - | - | - | - | - |
All numbers in USD currency